EUVIMEDEUVIMED entdecken
Crossref

Forced Degradation Studies of Dobutamine and Isolation, Identification, and Characterization of Potential Degradation Impurity by Preparative HPLC, LC–MS/MS. Development and Validation of Stability Indicative UPLC Method

Babu Reddy Goguladinne iD, Pulipaka Shyamala, K M V Narayana Rao

Biomedical Chromatography · 2025

DOI: 10.1002/bmc.70211 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Chromatography, 2025. Verfasst von Babu Reddy Goguladinne und 2 weiteren Autor:innen. Beteiligte Einrichtung: Aragen Life Sciences PVT Limited, Hyderabad, India. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry, Dobutamine. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dobutamine (DB) is a β1‐adrenergic agonist with weak β2 activity and α1 selective activity, which is used clinically in cases of cardiogenic shock. Most of the available literature methods for DB that are LCMS incompatible have limitations for the identification of impurities. The current study describes forced degradation studies of DB and the identification of impurities by mass analysis, assigning structure to the major degradant, and the development and validation of an LCMS‐compatible UPLC method. Impurity A (dopamine) highly polar impurity listed in the dopamine US Pharmacopeial Monograph, was retained in the developed method without an ion pair reagent. The method has been developed using Waters Acquity UPLC system equipped with Acquity UPLC HSS PFP column (2.1 mm × 100 mm, 1.8 μ), 0.05% TFA in water:ACN (95:5 %v/v) as Mobile Phase A, and 0.05% TFA in water:ACN (5:95 %v/v) as Mobile Phase B using a gradient program. DB degradation behavior was studied by subjecting it to acidic, basic, neutral, and oxidative conditions as per ICH guideline Q1A (R2). One of the major degradants was isolated by preparative HPLC and identified characterization by LCMS/MS and HRMS. The newly developed UPLC method was found to be specific with respect to degradation products, and the method has been validated according to the ICH guidelines.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tandem Mass SpectrometryDobutamineChromatography, High Pressure LiquidDrug StabilityDrug ContaminationReproducibility of ResultsLinear ModelsLimit of DetectionLiquid Chromatography-Mass Spectrometry

Stichwörter der Autor:innen

HRMSLCMSdegradation productsdobutaminedopaminepreparative HPLC

Substanzen

Dobutamine

Autor:innen und Institutionen

  • Aragen Life Sciences PVT Limited, Hyderabad, India.
  • Department of Chemistry, Andhra University, Visakhapatnam, India.

ORCID-Profile: Babu Reddy Goguladinne

Zitieren

APA

Goguladinne, B. R., Shyamala, P., & Rao, K. M. V. N. (2025). Forced Degradation Studies of Dobutamine and Isolation, Identification, and Characterization of Potential Degradation Impurity by Preparative HPLC, LC–MS/MS. Development and Validation of Stability Indicative UPLC Method. Biomedical Chromatography. https://doi.org/10.1002/bmc.70211

Vancouver

Goguladinne BR, Shyamala P, Rao KMVN. Forced Degradation Studies of Dobutamine and Isolation, Identification, and Characterization of Potential Degradation Impurity by Preparative HPLC, LC–MS/MS. Development and Validation of Stability Indicative UPLC Method. Biomedical Chromatography. 2025. doi:10.1002/bmc.70211

BibTeX
@article{Goguladinne2025,
  author = {Goguladinne, Babu Reddy and Shyamala, Pulipaka and Rao, K M V Narayana},
  title = {Forced Degradation Studies of Dobutamine and Isolation, Identification, and Characterization of Potential Degradation Impurity by Preparative HPLC, LC–MS/MS. Development and Validation of Stability Indicative UPLC Method},
  journal = {Biomedical Chromatography},
  year = {2025},
  doi = {10.1002/bmc.70211}
}
Kostenlos starten →